Author: admin

-ST101 Phase 2 data demonstrates activation of the tumor immune microenvironment in glioblastoma (GBM)– -ST316 Phase 1 data demonstrates antagonism of β-catenin-driven immune exclusion- TARRYTOWN, N.Y., Nov. 9, 2024 /PRNewswire/ — Sapience Therapeutics, Inc., a clinical-stage biotechnol

MONTREAL, Nov. 8, 2024 /CNW/ – 10:30 EST       Minister Petitpas Taylor will participate in a tour and lay a wreath at the National Field of Honour in Pointe-Claire. Note for media: Closed to media. Photos available upon request. 13:00 EST       The Minister will take part in &#822

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: